Tergynan Actions

sponsored
How times a day do you take this medicine?

Consists of Metronidazole, Neomycin, Nystatin

Actions of Metronidazole (Tergynan) in details

infoThe action of the drug on the human body is called Pharmacodynamics in Medical terminology. To produce its effect and to change the pathological process that is happening the body and to reduce the symptom or cure the disease, the medicine has to function in a specific way. The changes it does to the body at cellular level gives the desired result of treating a disease. Drugs act by stimulating or inhibiting a receptor or an enzyme or a protein most of the times. Medications are produced in such a way that the ingredients target the specific site and bring about chemical changes in the body that can stop or reverse the chemical reaction which is causing the disease.
sponsored

Pharmacology: Metronidazole (Tergynan) is a synthetic antibacterial compound. Disposition of Metronidazole (Tergynan) in the body is similar for both oral and intravenous dosage forms, with an average elimination half-life in healthy humans of eight hours.

The major route of elimination of Metronidazole (Tergynan) and its metabolites is via the urine (60-80% of the dose), with fecal excretion accounting for 6-15% of the dose. The metabolites that appear in the urine result primarily from side-chain oxidation [1-(β-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole and 2-methyl-5-nitroimidazole-1-yl-acetic acid] and glucuronide conjugation, with unchanged Metronidazole (Tergynan) accounting for approximately 20% of the total. Renal clearance of Metronidazole (Tergynan) is approximately 10 mL/min/1.73 m2.

Metronidazole (Tergynan) is the major component appearing in the plasma, with lesser quantities of the 2-hydroxymethyl metabolite also being present. Less than 20% of the circulating Metronidazole (Tergynan) is bound to plasma proteins. Both the parent compound and the metabolite possess in vitro bactericidal activity against most strains of anaerobic bacteria.

Metronidazole (Tergynan) appears in cerebrospinal fluid, saliva and breast milk in concentrations similar to those found in plasma. Bactericidal concentrations of Metronidazole (Tergynan) have also been detected in pus from hepatic abscesses.

Plasma concentration of Metronidazole (Tergynan) are proportional to the administered dose. An eight hour intravenous infusion of 100-4,000 mg of Metronidazole (Tergynan) in normal subjects showed a linear relationship between dose and peak plasma concentration.

In patients treated with intravenous Metronidazole (Tergynan), using a dosing regimen of 15 mg/kg loading dose followed six hours later by 7.5 mg/kg every six hours, peak steady-state plasma concentrations of Metronidazole (Tergynan) averaged 25 mcg/mL with trough (minimum) concentrations averaging 18 mcg/mL.

Decreased renal function does not alter the single-dose pharmacokinetics of Metronidazole (Tergynan). However, plasma clearance of Metronidazole (Tergynan) is decreased in patients with decreased liver function.

In one study newborn infants appeared to demonstrate diminished capacity to eliminate Metronidazole (Tergynan). The elimination half-life, measured during the first three days of life, was inversely related to gestational age. In infants whose gestational ages were between 28 and 40 weeks, the corresponding elimination half-lives ranged from 10.9 to 22.5 hours.

Microbiology: Metronidazole (Tergynan) is active in vitro against most obligate anaerobes, but does not appear to possess any clinically relevant activity against facultative anaerobes or obligate aerobes. Against susceptible organisms, Metronidazole (Tergynan) is generally bactericidal at concentrations equal to or slightly higher than the minimal inhibitory concentrations. Metronidazole (Tergynan) has been shown to have in vitro and clinical activity against the following organisms: Anaerobic Gram-Negative Bacilli, Including: Bacteroides species, including the Bacteroides fragilis group (B. fragilis, B. distasonis, B. ovatus, B. thetaiotaomicron, B. vulgatus), Fusobacterium species.

Anaerobic Gram-Positive Bacilli, Including: Clostridium species and susceptible strains of Eubacterium.

Anaerobic Gram-Positive Cocci, Including: Peptococcus species, Peptostreptococcus species.

How should I take Metronidazole (Tergynan)?

Do not use Metronidazole (Tergynan) in or near the eyes. Watering of the eyes may occur when the medicine is used too close to the eyes.

If Metronidazole (Tergynan) does get into your eyes, wash them out immediately, but carefully, with large amounts of cool tap water. If your eyes still burn or are painful, check with your doctor.

Before applying Metronidazole (Tergynan), thoroughly wash the affected area(s) with a mild, nonirritating cleanser, rinse well, and gently pat dry.

To use:

  • After washing the affected area(s), apply Metronidazole (Tergynan) with your fingertips.
  • Apply and rub in a thin film of medicine, using enough to cover the affected area(s) lightly. You should apply the medicine to the whole area usually affected by rosacea, not just to the pimples themselves.
  • Wash the medicine off your hands.

To help keep your rosacea under control, keep using Metronidazole (Tergynan) for the full time of treatment. You may have to continue using Metronidazole (Tergynan) every day for 9 weeks or longer. Do not miss any doses.

Dosing

The dose of Metronidazole (Tergynan) will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of Metronidazole (Tergynan). If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

  • For topical dosage forms (cream, gel, and lotion):
    • For rosacea:
      • Adults—Apply to the affected area(s) of skin two times a day, morning and evening, for nine weeks.
      • Children—Use and dose must be determined by your doctor.

Missed Dose

If you miss a dose of Metronidazole (Tergynan), apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Metronidazole (Tergynan) administration

infoAdministration of drug is important to know because the drug absorption and action varies depending on the route and time of administration of the drug. A medicine is prescribed before meals or after meals or along with meals. The specific timing of the drug intake about food is to increase its absorption and thus its efficacy. Few work well when taken in empty stomach and few medications need to be taken 1 or 2 hrs after the meal. A drug can be in the form of a tablet, a capsule which is the oral route of administration and the same can be in IV form which is used in specific cases. Other forms of drug administration can be a suppository in anal route or an inhalation route.
sponsored

Use this medication exactly as it was prescribed for you. Do not use the medication in larger amounts, or use it for longer than recommended by your doctor.

Wash your hands before and after using this medication.

Insert the cream into your vagina using the applicator as directed.

Your medication may come with disposable applicators. Use each applicator for only 1 day and then throw it away. If you use the medication twice daily, wash and rinse the applicator after your morning dose and use it again for your evening dose. Then throw it away and use a new applicator the next day.

Use Metronidazole (Tergynan) vaginal for the entire length of time prescribed by your doctor, even during your menstrual period. Your symptoms may get better before the infection is completely treated.

If the infection does not clear up after you have finished one course of therapy, or if your symptoms get worse, see your doctor. You may have another type of infection that Metronidazole (Tergynan) will not treat.

You may need to use a sanitary napkin during treatment, but do not use a tampon.

Metronidazole (Tergynan) vaginal can cause you to have unusual results with certain medical tests. Tell any doctor who treats you that you are using this medication.

Store Metronidazole (Tergynan) vaginal at room temperature away from moisture or heat. Do not allow it to freeze.

Metronidazole (Tergynan) pharmacology

infoPharmacokinetics of a drug can be defined as what body does to the drug after it is taken. The therapeutic result of the medicine depends upon the Pharmacokinetics of the drug. It deals with the time taken for the drug to be absorbed, metabolized, the process and chemical reactions involved in metabolism and about the excretion of the drug. All these factors are essential to deciding on the efficacy of the drug. Based on these pharmacokinetic principles, the ingredients, the Pharmaceutical company decides dose and route of administration. The concentration of the drug at the site of action which is proportional to therapeutic result inside the body depends on various pharmacokinetic reactions that occur in the body.
sponsored

Normal Subjects:

Following a single, intravaginal 5 gram dose of Metronidazole (Tergynan) Vaginal Gel (equivalent to 37.5 mg of Metronidazole (Tergynan)) to 12 normal subjects, a mean maximum serum Metronidazole (Tergynan) concentration of 237 ng/mL was reported (range: 152 to 368 ng/mL). This is approximately 2% of the mean maximum serum Metronidazole (Tergynan) concentration reported in the same subjects administered a single, oral 500 mg dose of Metronidazole (Tergynan) (mean Cmax = 12,785 ng/mL, range: 10,013 to 17,400 ng/mL). These peak concentrations were obtained in 6 to 12 hours after dosing with Metronidazole (Tergynan) Vaginal Gel and 1 to 3 hours after dosing with oral Metronidazole (Tergynan).

The extent of exposure [area under the curve (AUC)] of Metronidazole (Tergynan), when administered as a single intravaginal 5 gram dose of Metronidazole (Tergynan) Vaginal Gel (equivalent to 37.5 mg of Metronidazole (Tergynan)), was approximately 4% of the AUC of a single oral 500 mg dose of Metronidazole (Tergynan) (4977 ng-hr/mL and approximately 125,000 ng-hr/mL, respectively).

Dose-adjusted comparisons of AUCs demonstrated that, on a mg to mg comparison basis, the absorption of Metronidazole (Tergynan), when administered vaginally, was approximately half that of an equivalent oral dosage.

Patients with Bacterial Vaginosis:

Following single and multiple 5 gram doses of Metronidazole (Tergynan) Vaginal Gel to 4 patients with bacterial vaginosis, a mean maximum serum Metronidazole (Tergynan) concentration of 214 ng/mL on day 1 and 294 ng/mL (range: 228 to 349 ng/mL) on day five were reported. Steady state Metronidazole (Tergynan) serum concentrations following oral dosages of 400 to 500 mg BID have been reported to range from 6,000 to 20,000 ng/mL.

Microbiology:

The intracellular targets of action of Metronidazole (Tergynan) on anaerobes are largely unknown. The 5-nitro group of Metronidazole (Tergynan) is reduced by metabolically active anaerobes, and studies have demonstrated that the reduced form of the drug interacts with bacterial DNA. However, it is not clear whether interaction with DNA alone is an important component in the bactericidal action of Metronidazole (Tergynan) on anaerobic organisms.

Culture and sensitivity testing of bacteria are not routinely performed to establish the diagnosis of bacterial vaginosis.

Standard methodology for the susceptibility testing of the potential bacterial vaginosis pathogens, Gardnerella vaginalis, Mobiluncus spp., and Mycoplasma hominis, has not been defined. Nonetheless, Metronidazole (Tergynan) is an antimicrobial agent active in vitro against most strains of the following organisms that have been reported to be associated with bacterial vaginosis:

Bacteroides spp.

Gardnerella vaginalis

Mobiluncus spp.

Peptostreptococcus spp.

Actions of Neomycin (Tergynan) in details

infoThe action of the drug on the human body is called Pharmacodynamics in Medical terminology. To produce its effect and to change the pathological process that is happening the body and to reduce the symptom or cure the disease, the medicine has to function in a specific way. The changes it does to the body at cellular level gives the desired result of treating a disease. Drugs act by stimulating or inhibiting a receptor or an enzyme or a protein most of the times. Medications are produced in such a way that the ingredients target the specific site and bring about chemical changes in the body that can stop or reverse the chemical reaction which is causing the disease.
sponsored

Aminoglycosides like Neomycin (Tergynan) "irreversibly" bind to specific 30S-subunit proteins and 16S rRNA. Specifically Neomycin (Tergynan) binds to four nucleotides of 16S rRNA and a single amino acid of protein S12. This interferes with decoding site in the vicinity of nucleotide 1400 in 16S rRNA of 30S subunit. This region interacts with the wobble base in the anticodon of tRNA. This leads to interference with the initiation complex, misreading of mRNA so incorrect amino acids are inserted into the polypeptide leading to nonfunctional or toxic peptides and the breakup of polysomes into nonfunctional monosomes.

How should I take Neomycin (Tergynan)?

If you are using Neomycin (Tergynan) without a prescription, do not use it to treat deep wounds, puncture wounds, serious burns, or raw areas without first checking with your health care professional.

Do not use Neomycin (Tergynan) in the eyes.

Before applying Neomycin (Tergynan), wash the affected area with soap and water, and dry thoroughly.

For patients using the cream form of Neomycin (Tergynan):

  • Apply a generous amount of cream to the affected area, and rub in gently until the cream disappears.

For patients using the ointment form of Neomycin (Tergynan):

  • Apply a generous amount of ointment to the affected area, and rub in gently.

After Neomycin (Tergynan) is applied, the treated area may be covered with a gauze dressing if desired.

To help clear up your infection completely, keep using Neomycin (Tergynan) for the full time of treatment, even if your symptoms have disappeared. Do not miss any doses.

Dosing

The dose of Neomycin (Tergynan) will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of Neomycin (Tergynan). If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

  • For topical dosage forms (cream or ointment):
    • For minor bacterial skin infections:
      • Adults and children—Apply to the affected area(s) of the skin one to three times a day.

Missed Dose

If you miss a dose of Neomycin (Tergynan), apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Neomycin (Tergynan) administration

infoAdministration of drug is important to know because the drug absorption and action varies depending on the route and time of administration of the drug. A medicine is prescribed before meals or after meals or along with meals. The specific timing of the drug intake about food is to increase its absorption and thus its efficacy. Few work well when taken in empty stomach and few medications need to be taken 1 or 2 hrs after the meal. A drug can be in the form of a tablet, a capsule which is the oral route of administration and the same can be in IV form which is used in specific cases. Other forms of drug administration can be a suppository in anal route or an inhalation route.

Never take Neomycin (Tergynan) in larger amounts than recommended, or for longer than 2 weeks. High doses or long-term use of Neomycin (Tergynan) can cause serious kidney problems, or hearing loss that may not be reversible. The longer you take Neomycin (Tergynan), the more likely you are to develop these serious side effects. Follow the directions on your prescription label.

Measure liquid medicine with a special dose-measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.

Take this medicine for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Skipping doses may also increase your risk of further infection that is resistant to antibiotics. Neomycin (Tergynan) will not treat a viral infection such as the common cold or flu.

To be sure this medication is not causing harmful effects, your kidney function, and your nerve and muscle function will need to be tested often. You may also need hearing tests. Neomycin (Tergynan) can have long lasting effects on your body. Do not miss any follow up visits to your doctor for blood or urine tests.

If you are taking Neomycin (Tergynan) for hepatic coma, your treatment may also include a special diet. It is very important to follow the diet plan created for you by your doctor. You should become very familiar with the list of foods you should avoid to help control your condition.

If you need surgery, tell the surgeon ahead of time that you are using Neomycin (Tergynan). Neomycin (Tergynan) can interact with certain medicines that may be given during surgery.

Store at room temperature away from moisture and heat. Do not allow the liquid form of this medicine to freeze.

Neomycin (Tergynan) pharmacology

infoPharmacokinetics of a drug can be defined as what body does to the drug after it is taken. The therapeutic result of the medicine depends upon the Pharmacokinetics of the drug. It deals with the time taken for the drug to be absorbed, metabolized, the process and chemical reactions involved in metabolism and about the excretion of the drug. All these factors are essential to deciding on the efficacy of the drug. Based on these pharmacokinetic principles, the ingredients, the Pharmaceutical company decides dose and route of administration. The concentration of the drug at the site of action which is proportional to therapeutic result inside the body depends on various pharmacokinetic reactions that occur in the body.

Neomycin (Tergynan) sulfate is poorly absorbed from the normal gastrointestinal tract. The small absorbed fraction is rapidly distributed in the tissues and is excreted by the kidney in keeping with the degree of kidney function. The unabsorbed portion of the drug (approximately 97%) is eliminated unchanged in the feces.

Growth of most intestinal bacteria is rapidly suppressed following oral administration of Neomycin (Tergynan) sulfate, with the suppression persisting for 48-72 hours. Nonpathogenic yeasts and occasionally resistant strains of Enterobacter aerogenes (formerly Aerobacter aerogenes) replace the intestinal bacteria.

As with other aminoglycosides, the amount of systemically absorbed Neomycin (Tergynan) transferred to the tissues increases cumulatively with each repeated dose administered until a steady state is achieved. The kidney functions as the primary excretory path as well as the tissue binding site, with the highest concentration found in the renal cortex. With repeated dosings, progressive accumulation also occurs in the inner ear. Release of tissue-bound Neomycin (Tergynan) occurs slowly over a period of several weeks after dosing has been discontinued.

Protein binding studies have shown that the degree of aminoglycoside protein binding is low and, depending upon the methods used for testing, this may be between 0% and 30%.

Microbiology

In vitro tests have demonstrated that Neomycin (Tergynan) is bactericidal and acts by inhibiting the synthesis of protein in susceptible bacterial cells. It is effective primarily against gram-negative bacilli but does have some activity against gram-positive organisms. Neomycin (Tergynan) is active in vitro against Escherichia coli and the Klebsiella-Enterobacter group. Neomycin (Tergynan) is not active against anaerobic bowel flora.

If susceptibility testing is needed, using a 30 mcg disc, organisms producing zones of 16 mm or greater are considered susceptible. Resistant organisms produce zones of 13 mm or less. Zones greater than 13 mm and less than 16 mm indicate intermediate susceptibility.

Actions of Nystatin (Tergynan) in details

infoThe action of the drug on the human body is called Pharmacodynamics in Medical terminology. To produce its effect and to change the pathological process that is happening the body and to reduce the symptom or cure the disease, the medicine has to function in a specific way. The changes it does to the body at cellular level gives the desired result of treating a disease. Drugs act by stimulating or inhibiting a receptor or an enzyme or a protein most of the times. Medications are produced in such a way that the ingredients target the specific site and bring about chemical changes in the body that can stop or reverse the chemical reaction which is causing the disease.

Description: Nystatin (Tergynan) interferes w/ the cell wall permeability by binding to sterols, chiefly ergosterol, in the fungal cell membrane, thus allowing leakage of cellular contents.

Onset: Symptomatic relief of candidiasis: 24-72 hr.

Pharmacokinetics:

Absorption: Poorly absorbed from the GI tract; not absorbed through the skin or mucous membrane when applied topically.

Excretion: Via faeces, as unchanged drug.

How should I take Nystatin (Tergynan)?

Topical Nystatin (Tergynan) should not be used in the eyes.

Apply enough Nystatin (Tergynan) to cover the affected area.

For patients using the powder form of Nystatin (Tergynan) on the feet:

  • Sprinkle the powder between the toes, on the feet, and in socks and shoes.

The use of any kind of occlusive dressing (airtight covering, such as kitchen plastic wrap) over Nystatin (Tergynan) may increase the chance of irritation. Therefore, do not bandage, wrap, or apply any occlusive dressing over Nystatin (Tergynan) unless directed to do so by your doctor. When using Nystatin (Tergynan) on the diaper area of children, avoid tight-fitting diapers and plastic pants.

To help clear up your infection completely, keep using Nystatin (Tergynan) for the full time of treatment, even if your condition has improved. Do not miss any doses.

Dosing

The dose of Nystatin (Tergynan) will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of Nystatin (Tergynan). If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

  • For topical dosage forms (cream or ointment):
    • For fungus infections:
      • Adults and children—Apply to the affected area(s) of the skin two times a day.
  • For topical dosage form (powder):
    • For fungus infections:
      • Adults and children—Apply to the affected area(s) of the skin two or three times a day.

Missed Dose

If you miss a dose of Nystatin (Tergynan), take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Nystatin (Tergynan) administration

infoAdministration of drug is important to know because the drug absorption and action varies depending on the route and time of administration of the drug. A medicine is prescribed before meals or after meals or along with meals. The specific timing of the drug intake about food is to increase its absorption and thus its efficacy. Few work well when taken in empty stomach and few medications need to be taken 1 or 2 hrs after the meal. A drug can be in the form of a tablet, a capsule which is the oral route of administration and the same can be in IV form which is used in specific cases. Other forms of drug administration can be a suppository in anal route or an inhalation route.

Use exactly as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.

Do not use Nystatin (Tergynan) topical to treat any skin condition that has not been checked by your doctor.

Wash your hands before and after using this medication.

Clean and dry the skin before you apply Nystatin (Tergynan) topical.

Do not cover treated skin with bandages or dressings that do not allow air circulation unless your doctor tells you to.

Use this medication for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared.

Call your doctor if your symptoms do not improve, or if they get worse while using Nystatin (Tergynan) topical.

Do not share this medication with another person, even if they have the same symptoms you have.

Store at room temperature away from moisture and heat.

Nystatin (Tergynan) pharmacology

infoPharmacokinetics of a drug can be defined as what body does to the drug after it is taken. The therapeutic result of the medicine depends upon the Pharmacokinetics of the drug. It deals with the time taken for the drug to be absorbed, metabolized, the process and chemical reactions involved in metabolism and about the excretion of the drug. All these factors are essential to deciding on the efficacy of the drug. Based on these pharmacokinetic principles, the ingredients, the Pharmaceutical company decides dose and route of administration. The concentration of the drug at the site of action which is proportional to therapeutic result inside the body depends on various pharmacokinetic reactions that occur in the body.

Pharmacokinetics

Nystatin (Tergynan) Cream USP is not absorbed from intact skin or mucous membrane.

Microbiology

Nystatin (Tergynan) is an antibiotic which is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi, including Candida albicans, C. parapsilosis, C. tropicalis, C. guilliermondi, C. pseudotropicalis, C. krusei, Torulopsisglabrata, Tricophytonrubrum, T. mentagrophytes.

Nystatin (Tergynan) acts by binding to sterols in the cell membrane of susceptible species resulting in a change in membrane permeability and the subsequent leakage of intracellular components. On repeated subculturing with increasing levels of Nystatin (Tergynan), Candida albicans does not develop resistance to Nystatin (Tergynan). Generally, resistance to Nystatin (Tergynan) does not develop during therapy. However, other species of Candida (C. tropicalis, C. guilliermondi, C. krusei, and C. stellatoides) become quite resistant on treatment with Nystatin (Tergynan) and simultaneously become cross resistant to amphotericin as well. This resistance is lost when the antibiotic is removed.

Nystatin (Tergynan) exhibits no appreciable activity against bacteria, protozoa, or viruses.



References

  1. DailyMed. "BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
  2. DailyMed. "PREDNISOLONE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
  3. DailyMed. "HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Tergynan are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Tergynan. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported administration

No survey data has been collected yet


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 26 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2020 ndrugs.com All Rights Reserved